Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
3
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
3
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
merck
3
×
national
national blog main
national top stories
new york blog main
3
×
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
astrazeneca
cancer
cancer immunotherapy
car-t immunotherapy
clinical trials
deals
drug prices
eli lilly
johnson & johnson
medicare
What
drug
3
×
bio
companies
nash
news
roundup
approval
approved
away
biogen’s
biopharmaceutical
bringing
ceos
convo
dc
digital
disease
earlier
epidemic
executives
failures
fatty
fda
frenzied
gathered
groups
growing
hearing
held
known
led
littered
liver
lower
merck
new
pharma
pharmaceutical
price
prices
Language
Current search:
abbvie
×
merck
×
" bristol-myers squibb "
×
" new york blog main "
×
drug
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More